# Assessing Non-adjunctive CGM Safety at Home and in New Markets

> **NCT04585139** · NA · COMPLETED · sponsor: **DexCom, Inc.** · enrollment: 85 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Phase 1- Introduction to Dexcom G6 CGM

## Key facts

- **NCT ID:** NCT04585139
- **Lead sponsor:** DexCom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-06
- **Primary completion:** 2022-02-07
- **Final completion:** 2022-02-07
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2022-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585139, "Assessing Non-adjunctive CGM Safety at Home and in New Markets". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04585139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*